APREA THERAPEUTICS INC

APRE · NASDAQ

Updated at 2026-10-14 09:31:18

$0.60+1.16%
Today's High
$0.64
Today’s Low
$0.59
APREA THERAPEUTICS INC (APRE) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$0.61
Previous Close
$0.59
Volume
117.52K
Market Cap
$7.46M
P/E Ratio
--
EPS
$-1.07

Previous Day Range

$0.58$0.61

52-Week Range

$0.54$1.69

Company Overview

Sector
HEALTHCARE
Industry
Biotechnology
Sub-industry
BIOTECHNOLOGY
Headquarters
3805 OLD EASTON ROAD, DOYLESTOWN, PA, UNITED STATES, 18902
Country
US
Listing Date
2019-10-03
Fiscal Year End
December
Shares Outstanding
12.38M
CIK
0001781983

Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and markets cancer therapies that reactivate the mutant p53 tumor suppressor protein. The company is headquartered in Boston, Massachusetts.

Financial Metrics

Revenue

2026-06-30

$0

2026-03-31

$0

2025-12-31

$3.33K

2025-09-30

$1.84K

Operating Expenses

2026-06-30

$4.03M

2026-03-31

$3.42M

2025-12-31

$2.64M

2025-09-30

$3.11M

Net Income

2026-06-30

-$3.59M

2026-03-31

-$3.28M

2025-12-31

-$2.45M

2025-09-30

-$2.97M

Net Profit Margin

2026-06-30

--

2026-03-31

--

2025-12-31

-73.58K%

2025-09-30

-160.84K%

Earnings Per Share

2026-06-30

$-0.07

2026-03-31

$-0.22

2025-12-31

$-0.32

2025-09-30

$-0.47

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-06-30

-$3.58M

2026-03-31

-$3.28M

2025-12-31

-$2.45M

2025-09-30

-$2.96M

Effective Tax Rate

2026-06-30

--

2026-03-31

--

2025-12-31

--

2025-09-30

--

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.